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secretory mechanism requires the presence of CFTR protein which, in turn, is
activated by the interaction with SLC26A3. The main defect in CF has long been
thought to be the reduced epithelial chloride transport. However, recent works
turned this theory on its head, showing that the primary defect in cystic ﬁbrosis
is the inability to activate bicarbonate-driven ﬂuid secretion caused by chloride-
bicarbonate exchange. This mechanism requires the involvement of both SLC26 and
CFTR intact proteins: they form a unique complex by a direct interaction between
SLC26A3 “STAS-like” and CFTR “R” domains and by an indirect interaction
between PDZ domains of both proteins connected by the “PDZ-Binding Protein”.
Aim: The aims of the study were to evaluate if mutations in genes encoding some
SLC26 proteins (all characterized by the STAS-like and PDZ domains) may reduce
the the interactions between SLC26 genes (A3, A6, A7, A8 and A9) and CFTR
proteins, thus reducing the activation of CFTR. In other words mutations of SLC26
genes might be causative of CF.
Patients and methods: We analyzed, by direct sequencing, 25 patients bearing CF
and 25 patients bearing CFTR related disease, with one or both undetected CFTR
mutations. Furthermore, 100 non CF alleles were analyzed as controls.
Results and conclusions: For SLC26A3 we identiﬁed two mutations and two
intronic variants in CF patients. Similarly, for the other four genes, we identiﬁed
a number of gene variants, some of which speciﬁcally present in CF patients,
suggesting a possible role of SLC26A genes in the pathogenesis of CF.
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Cystic Fibrosis (CF) is the most common monogenic autosomal recessive disease in
Caucasians. In Italy, couples approaching assisted reproduction techniques (ART)
are usually subjected to the ﬁrst level CFTR mutation screening due to the high
frequency of CFTR carriers in general population (1/27, 3.7%); in addition, men
with congenital bilateral absence of vas deferens (CBAVD) and those with alter-
ations in spermatogenesis present CFTR mutations (70−88% and 7%, respectively).
Large CFTR gene rearrangements account for 1.5% of frequency in CF patients
with classical manifestations and 1% in CBAVD men.
The aim of this work was to understand if CFTR esonic rearrangements could be
a further possible cause of infertility.
Twenty-seven WT partners, belonging to discrepant couples after CFTR mutation
screening and scanning, were investigated for the presence of esonic rearrange-
ments by using QMPSF and MLPA analyses. In this preliminary study no large
esonic rearrangements were found. Our future perspectives are to add the esonic
rearrangements analysis to the ﬁrst level mutation screening in order to investigate
a larger cohort of patients.
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Cystic ﬁbrosis (CF) is characterized by speciﬁc age-related pathogens. Among
emerging pathogens in recent years a higher prevalence has been found for
Burkholderia cepacia, Stenotrophomonas maltophilia and Achromobacter xylosox-
idans.
Aim of our retrospective study was to establish the prevalence of CF commonly
associated and emerging pathogens in a cohort of patients followed in our Cystic
Fibrosis Unit for ten years. We studied a total of 109 patients (51 males, 42%
children, 58% adults) followed in our Unit from January 1996 to December 2006.
For each patient clinical records were examined, with microbiological ﬁndings and
respiratory functional data. The highest prevalence of Ps.aeruginosa, was observed
in 2004 (58%), followed by a clear decrease in the following years with the
lowest rate recorded in 2006 (40.3%). The prevalence of St.aureus showed a highly
irregular trend. The lowest prevalence was observed in 2004 (24%), with an increase
recorded in the following years, with a maximum value recorded in 2006 (63%). We
observed a clear increase in the prevalence of B. cepacia in the biennium 1996–1998
(13%) with a successive reduction to 5% in 2006. First isolations of A.Xylosoxidans
were observed in 2002–2004 with a maximal prevalence of 3% and a reduction in
the following years. None of the patients had a positive sputum for S. maltophilia
until 2002. The prevalence of this pathogen progressively increased to 8% in 2004.
In our population B.Cepacia has been associated to more severe clinical conditions
characterised by a more rapid decline in FEV1 (mean FEV1 = 45.7%) and a rapid
progression to respiratory failure (occurring in 25% of the patients with B.Cepacia).
S.Maltophilia exhibited a mild effect on respiratory function (mean FEV1= 67%)
and respiratory failure was present in 16.7% of the patients.
Generally, emerging pathogens have been observed only in the adult population.
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Background: SM (previously known as Pseudomonas maltophilia and then as
Xanthomonas maltophilia) is a non-fermentative, oxidase negative, Gram negative
bacillus, intrinsically resistant to carbapenems, virtually resistant to all beta-lactams
and often multiresistant. It has emerged as an important pathogen, particularly in
immunocompromised patients and it is also frequently isolated from airway samples
of CF patients; anyway its pathogenic role still remains not clearly understood.
Aim: The purpose of this study is to investigate if a patient to patient transmission
and/or an environmental acquisition has occurred among CF patients in follow up
at the CF centre of “Giannina Gaslini” Institute, Genova.
Materials and Methods: Since June 2004 a large collection of SM non-repetitive
strains has been set up at the General Laboratory of Analysis, it comprises 91 strains
isolated from 91/220 (41.4%) CF patients chronically/intermittently/sporadically
colonized, 39 strains from non-CF patients and 25 strains from environmental
sources (both hospital and community environment) for a total of 115 strains.
22/91 strains isolated from CF patients have been preliminarily analyzed. Genetic
ﬁngerprinting was performed by BOX-PCR according the protocol published by
Rademaker J.L. et al in 1998 using BOX-A1R primer. SM ATCC 13637 was used
as quality control strain. Cluster analysis was performed by Gel Compare II using
Pearson’s coefﬁcient.
Results: BOX PCR analysis generated a good resolution of molecular proﬁles,
allowing to perform an efﬁcient analysis by Gel Compare II. Among the 22 CF
analyzed strains a total of 12 different genotypes were found: 6 (50%) were not
shared among patients while the other 6 (50%) were shared by 3 groups of 2
patients, 1 group of 3 patients and 1 group of 4 patients.
Conclusions: BOX PCR is a suitable method to determine the genetic relatedness of
SM from CF patients. Although these are preliminary results, the data show clearly
that SM seems to easily circulate among patients, as one half of the analysed strains
are shared. Moreover, for a better comprehension, besides analysing the remaining
CF strains it will be fundamental to analyze the non-CF and the environmental
strains in order to establish if highly transmissible strains are circulating inside the
hospital and/or an environmental acquisition has occurred.
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Background: Colistin (CL) has emerged as a relevant therapeutic option for the
treatment of P. aeruginosa (PA) pulmonary infection in CF. The development of
resistance to this agent under selective pressure is not unexpected, even if it may
occur at lower extent compared with other antipseudomonal agents.
Objective:Monitoring the susceptibility to CL of a large collection of PA recovered
from Italian CF pts.
Methods: During 2006, 295 PA strains (151 non-mucoid and 113 mucoid and 31
SCV) from 178 pts from 4 Italian CF Centres (Genova, Ancona, Cerignola and
Soverato), were tested by CLSI disk diffusion method in Mueller–Hinton (MH)
agar (BD) for 12 antipseudomonal drugs and CL using a 10 mcg disk. (BD) with
PA 27853 ATCC as QC.
Isolates showing reduced susceptibility or resistance to CL disk were re-tested by
Etest method in MH agar, after at least 10 repeated sub-culture in blood agar. The
genetic relatedness of all isolates collection was previously determined by BOX-
PCR.
Results: Four PA isolates (1 mucoid, 1 non-mucoid and 2 SCV) from 4 patients (3
from Genova and 1 from Ancona) showed resistance to CL by disk diffusion and
conﬁrmed by Etest. The resistance level was high, with the Minimum Inhibitory
Concentration (MIC) ranging from 12 to 32mcg/ml. The 2 SCV strains were
multi-drug-resistant, while the mucoid isolate was susceptible to the other anti-
pseudomonal drugs tested. The CL-resistant PA isolates showed different genetic
proﬁles by BOX-PCR. 3/4 patients chronically colonized by CL-resistant PA had
several previous antibiotic treatments with aerosolised CL.
